Sexually Transmitted Diseases (STD) Diagnostics Market Size, Share Report, Analysis, Trends, Growth 2030

Sexually Transmitted Diseases (STD) Diagnostics Market

Sexually Transmitted Diseases (STD) Diagnostics Market- By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, and Human Immunodeficiency Virus Testing), By Testing Devices (Laboratory Equipment And Point Of Care Equipment): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2022–2028

Category: Healthcare Report Format : PDF Pages: 184 Report Code: ZMR-558 Published Date: Mar-2022 Status : Published

Global Sexually Transmitted Diseases (STD) Diagnostics Market size earned $151 billion in 2021 and is expected to earn $256 billion by 2028, growing at 8.3%.

Sexually Transmitted Diseases (STD) Dia Market

The global Sexually Transmitted Diseases (STD) Diagnostics Market accrued earnings worth approximately 151 (USD Billion) in 2021 and is predicted to gain revenue of about 256 (USD Billion) by 2028, is set to record a CAGR of nearly 8.3% over the period from 2022 to 2028. The study provides an assessment and analysis of the Sexually Transmitted Diseases (STD) Diagnostics Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).

Global Sexually Transmitted Diseases (STD) Diagnostics Market SizeRequest Free Sample

Sexually Transmitted Diseases (STD) Diagnostics Market: COVID-19 Impact Analysis

COVID-19 has become a global challenge for healthcare industry and will have long-lasting effect on sexually transmitted diseases (STD) diagnostics industry. Before pandemic there was rise in sexually transmitted diseases as there were no restrictions on movement of people and the latter could visit sex workers. However, lockdowns and restrictions on movement of people during COVID-19 times resulted in zero or negligible visits (frequency) of people to sex workers, thereby resulting in reduction in sexually transmitted disease infection among people. This has caused disruption in growth of sexually transmitted diseases (STD) diagnostics market. Apart from this, a large number of non-emergency visits were delayed during COVID pandemic and were converted into online tools for preventing doctors & patients from getting infected from COVID virus.

Global Sexually Transmitted Diseases (STD) Diagnostics MarketRequest Free Sample

Sexually Transmitted Diseases (STD) Diagnostics Market: Outlook

Early diagnosing of sexually transmitted diseases is predicted to minimize effect of disease on human health. Reportedly, if sexually transmitted diseases such as syphilis, gonorrhea, human papillomavirus, chlamydia, and genital herpes are not treated in time, it can result in long-term complications in affected persons. These complications encompass mental retardation, blindness, infertility, birth defects, cancer, heart disorders, and bone deformities in patients. Moreover, healthcare service providers diagnose sexually transmitted diseases through physically examination of subjects, blood tests, and through use of swabbed cultures at labs. Sexual transmitted diseases (STD) diagnosis involves lab testing and screening. Lab tests can recognize cause and identify co-infection through testing of blood, urine, and fluid samples. For the record, sexually transmitted disease patients are treated by prescribing them medications such as antiviral drugs and antibiotics.  

Furthermore, researchers at NIAID had carried out immunological studies for knowing as to why large number of sexually transmitted ailments in individuals is asymptomatic. Moreover, these studies have unleashed that how mutation in the infection accounted notably towards drug resistance in STD patients due to constant infection & co-infection. This can pose a big challenge to growth of sexually transmitted diseases (STD) diagnostics market.

Sexually Transmitted Diseases (STD) Diagnostics Market: Growth Factors

  • Growth Drivers: Rise in awareness about educational campaigns and supportive government schemes will proliferate size of sexually transmitted diseases (STD) diagnostics market over ensuing years. Furthermore, increase in persons having living relationships with many partners and people having sexual encounters with more than one partner resulting in causing of sexually transmitted diseases will boost market trends.
  • Restraints: Growing importance of sex education and reduction in taboo related to discussion over topics such as sexual activities & sexual arousal will hinder market surge. Rise in awareness about spread of sexually transmitted diseases such as HIV and need of avoiding it by taking preventive measures such as use of condoms can decrement growth of sexually transmitted diseases (STD) diagnostics market.
  • Opportunities: Rise in point of care testing activities due to influx of new diagnostic kits, reagents, and instruments will create new growth avenues for sexually transmitted diseases (STD) diagnostics market. Reportedly, technologically advanced equipment in diagnostics domain offers precise testing outcomes, thereby driving market size.
  • Challenges: Fluctuating costs of raw materials impacting demand and supply of diagnostics devices has severely impacted import & export of raw materials as well as production of sexually transmitted diseases devices, thereby posing a huge challenge to expansion of sexually transmitted diseases (STD) diagnostics market.

Sexually Transmitted Diseases (STD) Diagnostics Market: Segmentation

Based on segmentation, sexually transmitted diseases (STD) diagnostics market is segregated into type and testing devices. Based on type, the market is divided into chlamydia testing, gonorrhea testing, human papilloma virus testing, syphilis testing, herpes simplex virus testing, and human immunodeficiency virus testing. In terms of testing devices, the industry is sectored into laboratory equipment and point of care equipment.

Chlamydia Testing To Dominate Type Segment Over 2022-2028

Growth of chlamydia testing segment over forecasting timeframe can be attributed to low barrier protection and less awareness about chlamydia disease in under-developed and third world countries.

Laboratory Equipment Segment To Contribute Humungously Towards Market Size By 2028

Massive demand for laboratory devices for testing & diagnosing sexually transmitted diseases in individuals will boost segmental growth. Furthermore, most of diagnostic testing takes place in labs, thereby generating huge need of lab equipment.  

Report Scope:

 

Sexually Transmitted Diseases (STD) Diagnostics Market: Regional Landscape

Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market To Witness Sizable Surge In 2022-2028

Expansion of regional market over assessment period is due to lesser use of contraceptives by both men and women in underdeveloped as well as developing economies & rural areas of sub-continent. Apart from this, favorable regional government schemes for bringing improvement in sexual health of individuals will drive regional market growth.

Key Industry Participants

Mammoth players have strongly impacted expansion of sexually transmitted diseases (STD) diagnostics industry and are likely to maintain strong market position even in foreseeable future. They are Cepheid Inc., Roche Holdings AG, Affymetrix, Abbott Laboratories, Becton Dickinson and Company, DiaSorin, Hologic Inc., Danaher Corporation, bioMerieux SA, and Orasure Technologies.

Breakthroughs in Sexually Transmitted Diseases (STD) Diagnostics Market

  • In April 2019, Quest Diagnostics introduced three laboratory testing packages for diagnosing sexually transmitted diseases in the U.S. Reportedly, these packages can be purchased online for diagnosing frequently occurring sexually transmitted diseases across the U.S.
  • In February 2022, Lupin Limited – Mumbai-based Indian Pharmaceutical firm- received approval from U.S. FDA for use of its antibiotic Solosec for treating sexually transmitted infection referred as trichomoniasis and vaginal infection termed as bacterial vaginosis in women.
  • In February 2022, Trinity Biotech – a Medical Laboratory Company based in Ireland & specializing in production and marketing of clinically diagnostic products- has got approval of WHO for HIV screening test.

The global Sexually Transmitted Diseases (STD) Diagnostics Market is segmented as follows:

By Type

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing

By Testing Devices

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

Surge in awareness about educational campaigns and favorable government policies will steer growth of Sexually Transmitted Diseases (STD) Diagnostics Market over next six years.   

According to Zion market research report, The global Sexually Transmitted Diseases (STD) Diagnostics Market accrued earnings worth approximately 151 (USD Billion) in 2021 and is predicted to gain revenue of about 256 (USD Billion) by 2028, is set to record a CAGR of nearly 8.3% over the period from 2022 to 2028.

Asia Pacific will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is due to lesser use of contraceptives by both men and women in underdeveloped as well as developing economies & rural areas of sub-continent.  

The key market participants leveraging business sphere include Cepheid Inc., Roche Holdings AG, Affymetrix, Abbott Laboratories, Becton Dickinson and Company, DiaSorin, Hologic Inc., Danaher Corporation, bioMerieux SA, and Orasure Technologies.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed